Listed

Zoetis Inc.

ZTSNYSECIK 1555280HealthcareFiscal year ends Dec 31

Reports and events: 269 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Zoetis Inc., Reports and events
FiledFormWhat it isAccession number
2026-10-1311:32 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001555280-26-000044
2026-10-0820:16 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001555280-26-000042
2026-08-0620:17 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-26-338080
2026-08-0618:32 ET10-QQuarterly reportPeriod 2026-06-300001555280-26-000040
2026-08-0611:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001555280-26-000038
2026-05-2223:35 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001555280-26-000029
2026-05-2020:23 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001555280-26-000026
2026-05-0720:26 ET10-QQuarterly reportPeriod 2026-03-310001555280-26-000024
2026-05-0711:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001555280-26-000021
2026-04-0813:01 ETDEF 14AProxy statementPeriod 2025-12-310001555280-26-000015
2026-02-1221:49 ET10-KAnnual reportPeriod 2025-12-310001555280-26-000011
2026-02-1212:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001555280-26-000008
2026-02-0521:22 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001555280-26-000003
2025-12-1821:17 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-25-324853
2025-12-1121:17 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001555280-25-000282
2025-12-0213:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001555280-25-000280
2025-11-0420:02 ET10-QQuarterly reportPeriod 2025-09-300001555280-25-000274
2025-11-0412:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001555280-25-000272
2025-10-2812:33 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001555280-25-000266
2025-10-0920:24 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001555280-25-000264
2025-08-2720:21 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-25-189772
2025-08-1815:43 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-182451
2025-08-0517:58 ET10-QQuarterly reportPeriod 2025-06-300001555280-25-000261
2025-08-0511:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001555280-25-000259
2025-05-2220:26 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001555280-25-000213
2025-05-2120:22 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001555280-25-000209
2025-05-0617:29 ET10-QQuarterly reportPeriod 2025-03-310001555280-25-000203
2025-05-0611:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001555280-25-000201
2025-04-0913:02 ETDEF 14AProxy statementPeriod 2025-05-210001555280-25-000193
2025-02-1319:51 ET10-KAnnual reportPeriod 2024-12-310001555280-25-000102
2025-02-1312:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001555280-25-000100
2025-02-0621:20 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001555280-25-000022
2025-01-1313:04 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001555280-25-000005
2024-12-1221:18 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001555280-24-000342
2024-11-1211:27 ET8-K5.01 Change in control; 8.01 Other events; 9.01 Financial statements and exhibits0001555280-24-000335
2024-11-0418:52 ET10-QQuarterly reportPeriod 2024-09-300001555280-24-000332
2024-11-0412:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001555280-24-000330
2024-10-1020:26 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001555280-24-000326
2024-08-0616:41 ET10-QQuarterly reportPeriod 2024-06-300001555280-24-000299
2024-08-0611:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001555280-24-000295
2024-08-0120:32 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001555280-24-000290
2024-05-2411:12 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001555280-24-000262
2024-05-2310:43 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001555280-24-000257
2024-05-2220:40 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001555280-24-000252
2024-05-0216:26 ET10-QQuarterly reportPeriod 2024-03-310001555280-24-000249
2024-05-0211:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001555280-24-000247
2024-04-1620:09 ET8-K5.02 Departure or appointment of officers or directors0001555280-24-000237
2024-04-1011:45 ETDEF 14AProxy statementPeriod 2024-05-220001104659-24-045571
2024-04-0120:34 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001555280-24-000197
2024-02-1319:33 ET10-KAnnual reportPeriod 2023-12-310001555280-24-000143

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.